HOYA Co. (OTCMKTS:HOCPY - Get Free Report) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 3,000 shares, a decline of 26.8% from the March 31st total of 4,100 shares. Based on an average daily volume of 154,900 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company's stock are short sold.
HOYA Stock Up 0.6 %
OTCMKTS:HOCPY traded up $0.70 during trading hours on Tuesday, hitting $126.86. 27,628 shares of the company's stock traded hands, compared to its average volume of 39,154. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.35 and a current ratio of 5.04. HOYA has a twelve month low of $97.49 and a twelve month high of $148.27. The stock's fifty day moving average price is $113.68 and its two-hundred day moving average price is $124.23. The firm has a market cap of $43.88 billion, a P/E ratio of 32.28, a P/E/G ratio of 2.38 and a beta of 0.93.
HOYA (OTCMKTS:HOCPY - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The technology company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $0.99 by ($0.01). HOYA had a net margin of 24.17% and a return on equity of 21.34%. The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.50 billion. On average, research analysts expect that HOYA will post 3.66 earnings per share for the current fiscal year.
HOYA Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Recommended Stories
Before you consider HOYA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HOYA wasn't on the list.
While HOYA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.